EFFET PARFAIT

Product NDC
13537-023
11-digit product format
135370023
Labeler code
13537
Product ID
13537-023_906dbbed-59ec-44b0-a595-d67a62452f61
Type
HUMAN OTC DRUG
Nonproprietary name
Octinoxate and Titanium Dioxide
Dosage form
LOTION
Route
TOPICAL
Labeler
Ventura Corporation Ltd.
Application
part352
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2011-08-10
Marketing end
0000-00-00
Substance
OCTINOXATE; TITANIUM DIOXIDE
Active strength
0 mL/mL; mL/mL
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct13537-023DDiscontinued by firm2026-10-15
excluded packagepackage13537-02313537-023-02DDiscontinued by firm2026-10-15
excluded packagepackage13537-02313537-023-04DDiscontinued by firm2026-10-15
excluded packagepackage13537-02313537-023-06DDiscontinued by firm2026-10-15
excluded packagepackage13537-02313537-023-08DDiscontinued by firm2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 110 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage13537-023-02DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage13537-023-06DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage13537-023-04DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage13537-023-08DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage13537-023-02DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage13537-023-06DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage13537-023-04DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage13537-023-08DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductIInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage13537-023-02IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage13537-023-08IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage13537-023-04IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage13537-023-06IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductIInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage13537-023-02IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage13537-023-08IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage13537-023-04IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage13537-023-06IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductIInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage13537-023-02IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage13537-023-08IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage13537-023-04IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage13537-023-06IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductIInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage13537-023-02IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage13537-023-08IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage13537-023-04IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage13537-023-06IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductIInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage13537-023-02IInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage13537-023-08IInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage13537-023-04IInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage13537-023-06IInactivated by FDA302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductIInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage13537-023-02IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage13537-023-08IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage13537-023-04IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage13537-023-06IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductIInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage13537-023-02IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage13537-023-08IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage13537-023-04IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage13537-023-06IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductIInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage13537-023-02IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage13537-023-08IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage13537-023-04IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage13537-023-06IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductIInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage13537-023-02IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage13537-023-08IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage13537-023-04IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage13537-023-06IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductIInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage13537-023-02IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage13537-023-08IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage13537-023-04IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage13537-023-06IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
OctinoxateACTIVE INGREDIENT4Y5P7MUD51EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Titanium DioxideACTIVE INGREDIENT15FIX9V2JPEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
OctinoxateACTIVE MOIETY4Y5P7MUD51EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Titanium DioxideACTIVE MOIETY15FIX9V2JPEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Alkyl (C12-15) BenzoateINACTIVE INGREDIENTA9EJ3J61HQEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Alpha-Tocopherol AcetateINACTIVE INGREDIENT9E8X80D2L0EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Aluminum OxideINACTIVE INGREDIENTLMI26O6933EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Butylated HydroxytolueneINACTIVE INGREDIENT1P9D0Z171KEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Candelilla WaxINACTIVE INGREDIENTWL0328HX19EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Carnauba WaxINACTIVE INGREDIENTR12CBM0EIZEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Cetearyl GlucosideINACTIVE INGREDIENT09FUA47KNAEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Cetostearyl AlcoholINACTIVE INGREDIENT2DMT128M1SEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
CholesterolINACTIVE INGREDIENT97C5T2UQ7JEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Cyclomethicone 5INACTIVE INGREDIENT0THT5PCI0REFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Cyclomethicone 6INACTIVE INGREDIENTXHK3U310BAEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Diazolidinyl UreaINACTIVE INGREDIENTH5RIZ3MPW4EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Ferric Oxide RedINACTIVE INGREDIENT1K09F3G675EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Ferric Oxide YellowINACTIVE INGREDIENTEX438O2MRTEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Ferrosoferric OxideINACTIVE INGREDIENTXM0M87F357EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
GlycerinINACTIVE INGREDIENTPDC6A3C0OXEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Linoleic AcidINACTIVE INGREDIENT9KJL21T0QJEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Linolenic AcidINACTIVE INGREDIENT0RBV727H71EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
MethylparabenINACTIVE INGREDIENTA2I8C7HI9TEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
OctyldodecanolINACTIVE INGREDIENT461N1O614YEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Oleth-5INACTIVE INGREDIENT1GH33785AYEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
PetrolatumINACTIVE INGREDIENT4T6H12BN9UEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
PropanediolINACTIVE INGREDIENT5965N8W85TEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Propylene Glycol Dicaprylate/DicaprateINACTIVE INGREDIENTO4446S9CRAEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
PropylparabenINACTIVE INGREDIENTZ8IX2SC1OHEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Ribes Nigrum SeedINACTIVE INGREDIENTEHO0V3IRF5EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Silicon DioxideINACTIVE INGREDIENTETJ7Z6XBU4EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
TribeheninINACTIVE INGREDIENT8OC9U7TQZ0EFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
TriethoxycaprylylsilaneINACTIVE INGREDIENTLDC331P08EEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
waterINACTIVE INGREDIENT059QF0KO0REFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
XylitolINACTIVE INGREDIENTVCQ006KQ1EEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Yellow WaxINACTIVE INGREDIENT2ZA36H0S2VEFFET PARFAIT (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1